RCS - Savannah Resources - MoU with local healthcare group

Savannah ResourcesAnnouncement

27/10/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251027:nRSa8390Ea&default-theme=true

RNS Number : 8390E  Savannah Resources PLC  27 October 2025

 

 

27 October 2025

 

Savannah Resources Plc

(AIM: SAV) ('Savannah', or the 'Company')

 

MoU with local healthcare group

 

Savannah Resources Plc, the developer of the Barroso Lithium Project in
Portugal, a 'Strategic Project' under the European Critical Raw Materials Act
and Europe's largest spodumene lithium deposit (the 'Project'), is pleased to
announce the signing of a Memorandum of Understanding (MoU) with Terra Quente
Saúde Group, an established local healthcare provider, to develop a strategic
partnership focused on greater provision of healthcare services into the area
surrounding the Barroso Lithium Project, in Boticas.

 

This collaboration comes as part of Savannah's commitment to work with local
partners, contributing to an improvement in living conditions in areas close
to the Project within the Barroso Trás-os-Montes region. The choice of Terra
Quente Saúde Group as a partner reflects a sharing of fundamental values: the
active presence within local communities, the desire to contribute to the
social and economic development of the territory, and the search for greater
understanding of the specific needs of the population of the region.

 

The MoU lays the groundwork for collaboration between the two entities, which
will work together in the coming months to define the specific contours of the
partnership in order to soon announce concrete initiatives that strengthen
access to healthcare and promote the well-being of both Savannah employees and
their families and, in the longer term, the local populations around the
Project.

 

Emanuel Proença, CEO of Savannah said, "We believe that this is an important
step to integrate the Barroso Lithium Project into a broader territorial
development, which goes beyond critical raw material production and actively
contributes to improving the quality of life in our region. Being able to do
it with the Terra Quente Saúde Group as our partner excites us, because we
share the same values and the same ambition to develop local and innovative
projects for a region of Trás-os-Montes to provide more opportunities in the
future".

 

Manuel Lemos, Director of the Terra Quente Saúde Group said: "It is with
great ambition that we take this step, one more in our journey to be more and
more a key player in the construction of a Trás-os-Montes region with an
exciting future. We will support Savannah to identify the best ways to provide
the necessary health care for the current and future populations of the
villages closest to the Barroso Lithium Project, benefiting from our strong
experience and continued presence in the Trás-os-Montes territory, and our
deep knowledge of the local area".

 

Further information

 

About Terra Quente Saúde Group

The Terra Quente Saúde Group currently operates three hospitals in
Trás-os-Montes, more specifically in Chaves, Mirandela and Bragança, and
opened two Clinics in Mogadouro and Vila Nova de Foz Côa earlier this year.
The Group's strategy to offer quality local services to populations located in
the interior of the country has allowed people to reduce their travel in
search of health care by hundreds of kilometres.

 

The two companies will now explore possible initiatives such as the regular
location of a doctor and/or nurse or the opening of health posts in one of the
villages in the region.

 

 

Savannah - Enabling Europe's energy transition.

 

**ENDS**

Follow @SavannahRes on X (Formerly known as Twitter)

Follow Savannah Resources on LinkedIn

 

For further information please visit www.savannahresources
(https://www.savannahresources.com/) .com or contact:

 

 Savannah Resources PLC                                            Tel: +44 20 7117 2489

 Emanuel Proença, CEO
 SP Angel Corporate Finance LLP (Nominated Advisor & Broker)       Tel: +44 20 3470 0470

 David Hignell/ Charlie Bouverat (Corporate Finance)

 Grant Barker/Abigail Wayne (Sales & Broking)

  www.savannahresources
 Canaccord Genuity Limited (Joint Broker)                          Tel: +44 20 7523 8000

 James Asensio / Charlie Hammond (Corporate Broking)

 Ben Knott (Sales)
 Media Relations

 Savannah Resources: Antonio Neves Costa, Communications Manager   Tel: +351 962 678 912

 

About Savannah

Savannah Resources is a mineral resource development company and the sole
owner of the Barroso Lithium Project (the 'Project') in northern Portugal. The
Project is the largest battery grade spodumene lithium resource outlined to
date in Europe and was classified as a 'Strategic Project' by the European
Commission under the Critical Raw Materials Act in March 2025.

 

Through the Project, Savannah will help Portugal to play an important role in
providing a long-term, locally sourced, lithium raw material supply for
Europe's lithium battery value chain. Once in operation the Project will
produce enough lithium (contained in c.190,000tpa of spodumene concentrate)
for approximately half a million vehicle battery packs per year and hence make
a significant contribution towards the European Commission's Critical Raw
Material Act goal of a minimum 10% of European endogenous lithium production
from 2030.

 

Savannah is focused on the responsible development and operation of the
Barroso Lithium Project so that its impact on the environment is minimised and
the socio-economic benefits that it can bring to all its stakeholders are
maximised.

 

The Company is listed and regulated on the London Stock Exchange's Alternative
Investment Market (AIM) and trades under the ticker "SAV".

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEADEKAEKSFFA



            Copyright 2019 Regulatory News Service, all rights reserved